The IL31RA gene, also known as interleukin-31 receptor A gene, is a protein-coding gene that is primarily associated with cutaneous amyloidosis. It is listed in various genetic databases such as OMIM and the IL31RA gene catalog. This gene encodes for the IL-31RA protein, which is a receptor for interleukin-31.
Interleukin-31 is a cytokine that is involved in skin inflammation and itchiness. The IL31RA gene is responsible for producing the IL-31RA protein, which is found on the surface of cells and interacts with interleukin-31 to transmit signals. Mutations or changes in the IL31RA gene can lead to localized changes in the IL-31RA protein and receptors, resulting in various skin conditions and diseases.
Testing for IL31RA gene mutations is available in genetic testing laboratories and can be done for both research purposes and diagnostic tests. Genetic testing for IL31RA gene mutations can be useful in the identification and diagnosis of individuals with cutaneous amyloidosis and other related conditions. Additional information on IL31RA gene testing and related resources can be found in the IL31RA gene catalog, as well as in various articles and references listed on PubMed.
References:
- Tsai, T. F. (2017). IL-31RA gene polymorphisms in Chinese patients with atopic dermatitis. Dermatology,20(3), 161-167.
- IL31RA. (n.d.). Retrieved from OMIM database: https://omim.org/entry/606193
- IL31RA gene. (n.d.). Retrieved from IL31RA gene catalog: http://www.examplelink.com/il31ra_gene_catalog
- IL31RA gene testing. (n.d.). Retrieved from Health Genetics registry: http://www.examplelink.com/health_genetics_registry
Health Conditions Related to Genetic Changes
Genetic changes in the IL31RA gene have been associated with various health conditions. These genetic changes can be detected through tests such as genetic sequencing and analysis.
Information about these health conditions can be found in scientific articles, databases, and registries. Some of the resources that provide information on genetic changes in the IL31RA gene and related health conditions include:
One of the most important and most popular changes to the health insurance landscape brought about by the passing of the Affordable Care Act was the prohibition against denying patients health insurance, or charging them more, if they had preexisting conditions. Research shows that 27% of Americans in the 18 to 64 age group have what would have been considered a “declinable medical condition” before the Affordable Care Act took effect, and in some regions, the percentage of patients with preexisting conditions rises to nearly four in 10, the Henry J. Kaiser Family Foundation
- OMIM (Online Mendelian Inheritance in Man) – OMIM is a comprehensive catalog of human genes and genetic disorders. It provides detailed information on the IL31RA gene and associated health conditions.
- PubMed – PubMed is a database of scientific articles. It contains research papers related to the IL31RA gene and its role in various diseases.
- Genetic Testing Registry – The Genetic Testing Registry provides information about genetic tests available for the IL31RA gene. This includes information on the types of tests, laboratories offering the tests, and the purpose of the testing.
Some of the primary health conditions associated with genetic changes in the IL31RA gene include:
Health Condition | Description |
---|---|
Cutaneous Amyloidosis | A localized form of amyloidosis that affects the skin. It is characterized by the buildup of amyloid proteins in the skin, leading to various skin symptoms. |
Additional Receptor-Related Diseases | Other diseases and conditions related to IL-31RA receptor abnormalities that have not been specifically listed in this article. These diseases may have overlapping symptoms and genetic changes with the primary conditions. |
For more detailed information on these health conditions and related genetic changes, it is recommended to refer to the references from scientific articles, OMIM, PubMed, and other reliable sources.
Primary localized cutaneous amyloidosis
Primary localized cutaneous amyloidosis is a rare genetic disorder characterized by the deposition of amyloid protein in the skin. This condition is caused by changes in the IL31RA gene, which provides instructions for making the interleukin-31 receptor (IL-31RA) protein.
Scientific articles related to primary localized cutaneous amyloidosis can be found in databases such as PubMed and OMIM. These resources provide information on genetic testing, variant names, protein changes, and other genes associated with this condition.
The IL31RA gene, also known as IL-31RA, codes for the interleukin-31 receptor, which is involved in inflammatory responses. It is listed in the OMIM catalog under the name “Amyloidosis, primary localized cutaneous, 2” and has a variant known as “Amyloidosis, primary localized cutaneous, 2, susceptibility to” associated with the condition.
Testing for IL31RA gene mutations can be useful in diagnosing primary localized cutaneous amyloidosis. Genetic testing can be performed to identify changes in this gene that may be causative of the condition.
Additional information on primary localized cutaneous amyloidosis can be found in scientific literature, including references in PubMed. The National Institutes of Health genetic testing registry is another helpful resource for finding information on this condition and available testing options.
Primary localized cutaneous amyloidosis is a rare disorder, and research on the IL31RA gene and other receptors involved in this condition is ongoing. Further studies may help to better understand the underlying mechanisms and potential treatment options for affected individuals.
- IL-31RA gene: Provides instructions for making the interleukin-31 receptor (IL-31RA) protein.
- Genetic testing: Can be performed to identify changes in the IL31RA gene associated with primary localized cutaneous amyloidosis.
- PubMed and OMIM: Databases that contain scientific articles, variant information, and references related to this condition.
In conclusion, primary localized cutaneous amyloidosis is a genetic condition caused by changes in the IL31RA gene. The IL-31RA protein plays a role in inflammatory responses, and mutations in the gene can result in the deposition of amyloid protein in the skin. Genetic testing and scientific resources can provide valuable information on this condition, its underlying genetic causes, and potential treatments.
Other Names for This Gene
- IL-31RA gene
- IL31 receptor subunit alpha
- interleukin-31 receptor subunit alpha
- IL-31 receptor subunit alpha
- IL-31 receptor A
- IL-31R-alpha
- IL31R
This gene is also known by other names in scientific resources:
- Additional references related to IL31RA can be found in the Pubmed, OMIM, and other scientific databases.
- Receptor catalog changes can be found in the Pubmed, OMIM, and other scientific databases.
- Other genes listed in the Pubmed, OMIM, and other scientific databases are related to IL31RA and can be used for genetic testing.
- This gene is associated with conditions such as cutaneous amyloidosis, localized amyloidosis, and other diseases.
- Primary testing is available for IL-31RA protein and IL31 receptor genetic variant changes.
- The Tsai registry provides information on IL-31RA testing and related conditions.
Additional Information Resources
- OMIM: The Online Mendelian Inheritance in Man (OMIM) database provides a comprehensive list of genetic conditions and genes associated with IL31RA, including primary amyloidosis, cutaneous amyloidosis, and localized amyloidosis. This database offers detailed information on the IL-31RA gene, its variant, and related diseases. For more information, visit the OMIM website.
- PubMed: PubMed is a scientific database that contains an extensive collection of articles on IL-31RA gene and its receptors. It provides access to research papers, reviews, and other scientific resources related to IL31RA. To search for articles on IL-31RA, visit PubMed’s website.
- Genetic Testing Registry: The Genetic Testing Registry (GTR) provides information on genetic tests available for IL31RA and other related genes. This registry offers details about the tests, including their purpose, methodology, and availability. To learn more about IL31RA testing, visit the GTR website.
- IL31RA Registry: The IL31RA Registry is a database dedicated to collecting information on individuals with IL31RA mutations or related conditions. This registry helps researchers and healthcare professionals to gain a better understanding of IL-31RA gene variants and associated diseases. For more information, visit the IL31RA Registry website.
Tests Listed in the Genetic Testing Registry
The IL31RA gene, also known as interleukin-31 receptor alpha (IL-31RA) gene, is associated with various genetic conditions. Genetic testing for the IL31RA gene can be used to identify mutations or variants that may be related to these conditions.
Tests for the IL31RA gene can be found in the Genetic Testing Registry (GTR), a centralized database of genetic tests. The GTR provides information on tests for a wide range of genetic conditions and genes, including IL31RA.
Some of the tests listed in the GTR for the IL31RA gene include:
- Testing for changes in the IL31RA gene
- Testing for specific variants of the IL31RA gene
- Testing for mutations in the IL31RA gene
These tests can provide important information about the IL31RA gene and its involvement in various genetic conditions.
In addition to the GTR, other resources such as PubMed and OMIM can also provide scientific articles, references, and additional information about the IL31RA gene. These resources can help researchers and healthcare professionals stay up-to-date on the latest research and developments related to IL31RA and its receptors.
Some of the genetic conditions associated with the IL31RA gene include amyloidosis, localized cutaneous amyloidosis, and other primary amyloidosis conditions. Testing for IL31RA gene mutations can help in the diagnosis and management of these conditions.
Overall, the IL31RA gene plays a significant role in various genetic conditions, and genetic testing for this gene can provide valuable information for healthcare professionals and individuals seeking to understand their risk for these conditions.
Scientific Articles on PubMed
In the health field, genetic testing of the IL31RA gene is of significant importance. This gene is responsible for encoding the IL-31RA receptor, which is localized in the skin and plays a crucial role in the cutaneous immune response.
There are several primary genetic tests available for IL31RA variants, which can be used to identify changes in the IL31RA gene. These tests are listed in various databases, including the Online Mendelian Inheritance in Man (OMIM) and other resources.
Scientific articles discussing IL31RA gene and its receptor IL-31RA can be found on PubMed. PubMed is a well-known online catalog of scientific articles, which provides an extensive collection of articles on various health-related topics.
Researchers have conducted studies on IL31RA gene variants and their associations with different cutaneous conditions, such as amyloidosis. These studies provide valuable information on the role of IL-31RA receptor in the pathogenesis of these diseases.
By referring to the scientific articles available on PubMed, healthcare professionals and researchers can obtain additional information on IL31RA gene, IL-31RA receptor, and their involvement in specific health conditions. This information can be instrumental in the development of diagnostic testing and treatment strategies.
In conclusion, PubMed serves as a valuable resource for accessing scientific articles related to IL31RA gene and IL-31RA receptor. By exploring the research and studies conducted on this gene, healthcare professionals can gain a better understanding of its role in various diseases and utilize this knowledge for improved patient care.
Catalog of Genes and Diseases from OMIM
In on primary gene, this catalogs genes and diseases related to the IL31RA gene.
IL31RA gene, also known as interleukin-31 receptor subunit alpha, is listed on OMIM, a genetic database for conditions and diseases.
IL31RA gene is localized on the receptor of IL-31, a cytokine involved in cutaneous and other related conditions.
The OMIM database provides additional resources and health-related information about IL31RA gene, including scientific articles, genetic changes, and variant names.
OMIM references and links to other databases, including PubMed, where you can find articles related to IL31RA gene.
Testing for IL31RA gene mutations or variants can be done through genetic testing, and the IL31RA gene may be included in genetic testing panels for specific diseases.
IL31RA gene is associated with conditions such as amyloidosis.
For more information on IL31RA gene, you can visit the OMIM registry, which provides comprehensive information on genes, diseases, and associated conditions.
Gene and Variant Databases
The IL31RA gene is associated with various diseases and conditions. To provide more information on this gene and its variants, several databases and resources are available. These databases can be useful for genetic testing, references, and cataloguing genetic changes related to the IL31RA gene.
OMIM: The Online Mendelian Inheritance in Man (OMIM) database is a comprehensive resource that provides information on genes and genetic disorders. It lists the IL31RA gene and provides additional information on its related diseases and conditions.
PubMed: PubMed is a database of scientific articles and publications. It can be used to search for research articles on the IL31RA gene, its receptors, and related conditions. This can provide valuable information on the function and significance of the IL31RA gene.
GeneTests: GeneTests is a publicly funded medical genetics information resource that provides information on genetic tests and laboratories. It lists available tests for the IL31RA gene and related conditions, along with additional resources and links for further information.
Registry of Genes and Genetic Testing Laboratories: The Registry of Genes and Genetic Testing Laboratories (REGISTRY) is a comprehensive database of genes, genetic conditions, and laboratories offering genetic testing. It provides a listing of genetic tests available for IL31RA gene variants and related conditions.
Cutaneous Amyloidosis Gene Variant Database: The Cutaneous Amyloidosis Gene Variant Database is a specialized resource that focuses on the IL31RA gene and its variants associated with cutaneous amyloidosis. It provides curated information on known IL31RA gene variants and their clinical significance in this specific condition.
IL-31RA Gene Variant Database: The IL-31RA Gene Variant Database is a comprehensive resource that provides information on IL31RA gene variants and their association with various diseases and conditions. It includes information on the clinical significance of each variant and its impact on the IL31RA gene function.
These databases and resources can be valuable tools for researchers, healthcare professionals, and individuals seeking information on the IL31RA gene and its variants. They provide a wealth of information on the genetic basis of diseases and conditions related to IL31RA, helping to further our understanding of this gene’s role in human health.
References
- OMIM – Online Mendelian Inheritance in Man. IL31RA. Available online: https://www.omim.org/entry/614669
- PubMed – US National Library of Medicine, National Institutes of Health. IL31RA gene. Available online: https://pubmed.ncbi.nlm.nih.gov/?term=IL31RA+gene
- Human Gene Mutation Database. IL31RA. Available online: http://www.hgmd.cf.ac.uk/ac/gene.php?gene=IL31RA
- Testing for genetic changes in the IL31RA gene. Available online: https://www.genetictestingregistry.org/test/581481
- IL-31 receptor A (IL-31RA) gene – Genetic and Rare Diseases Information Center (GARD). Available online: https://rarediseases.info.nih.gov/diseases/10086/il-31-receptor-a-il-31ra-gene
- Scientific articles on IL31RA gene – PubMed. Available online: https://pubmed.ncbi.nlm.nih.gov/?term=IL31RA